SPY315.50+1.72 0.55%
DIA260.40+1.36 0.53%
IXIC10,448.65+104.76 1.01%

Establishment Labs And Puregraft Terminate Exclusive Distribution Partnership

On June 18, 2020, Establishment Labs Holdings Inc. (the "Company") and Puregraft LLC relationship terminated under the Exclusive Distribution Agreement by and between the Company, Puregraft LLC and its parent

Benzinga · -

On June 18, 2020, Establishment Labs Holdings Inc. (the "Company") and Puregraft LLC relationship terminated under the Exclusive Distribution Agreement by and between the Company, Puregraft LLC and its parent Bimini Technologies, LLC dated September 7, 2016 (as amended, the "Distribution Agreement").  Pursuant to the Distribution Agreement, the Company was the exclusive distributor, outside the United States and Canada, of the Puregraft line of products for autologous adipose tissue harvesting and redistribution.  The Company and Puregraft remain in discussions regarding the terms of the termination of the Distribution Agreement.